Mounjaro (Tirzepatide) is a prescription medication for adults who are looking to lose weight and improve health outcomes related directly to obesity
The company is still expecting a good year, projecting its weight loss business to hit $725 million in 2025
Less urgent but still worth reporting: side effects that do not improve after seven days at any dose level, persistent diarrhea that interferes with daily activities, significant hair thinning (which can occur during rapid weight loss phases and may relate to nutritional deficiencies rather than medication directly), mood changes including increased anxiety or depression, and hair loss patterns that seem disproportionate to weight loss speed
Patients are often advised to use a non-oral method or add a barrier method for four weeks after starting and for four weeks after each dose increase
In those situations, a product like GLP-1 Daily Support may be a helpful option to explore alongside a clinicians guidance
Step-by-Step Reconstitution Protocols for CJC-1295 Research Peptide in Lab Settings Last Updated: April 2, 2026 | Reading Time: Approximately ~9 minutes | Author: Palmetto Peptides Research Team Quick Answer Reconstituting CJC-1295 requires bacteriostatic water (BAC water) and sterile laboratory technique